Search Results 51-60 of 1311 for ☃휴대폰소액결제현금화 (010-9675-8884) 카톡 ON8884 콘텐츠이용료소액결제☃

  1. A Study Comparing 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR to Treat Patients with Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours - Mayo Clinic

    A Study Comparing 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR to Treat Patients with Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid ...

  2. Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer - Mayo Clinic

    Androgens can cause the growth of prostate cancer cells. Antihormone therapy, such as bicalutamide, may lessen the amount of androgens made by the body. Akt ...

  3. A Study to Assess Markers of Aging Process - Mayo Clinic

    The purose of this study is to develop assays to identify markers related to aging processes in a variety of biospecimens, including but limited to blood, urine ...

  4. Safety Study of Mocetinostat in Combination With Azacitidine in Subjects With MDS - Mayo Clinic

    Mocetinostat is an orally administered histone deacetylase (HDAC) inhibitor. Azacitidine is a hypomethylating agent (HMA) used to treat MDS. In this study, ...

  5. A Study of BHV-3241 in Subjects with Multiple System Atrophy - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. COVID-19 Residual Biobank (Enrolling by Invitation Only) - Mayo Clinic

    The purpose of this study is to collect residual (waste) blood, urine, and stool specimens remaining from clinician order testing and corresponding clinical and ...

  7. A Study of INCB039110 in Combination with Corticosteroids for the Treatment of Acute Graft Versus Host Disease - Mayo Clinic

    The purpose of this study is to determine if INCB039110 in combination with corticosteroids is safe and tolerable for treating patients with Grade IIB-IVD acute ...

  8. Registry of Patients Treated With Systemic Mold-Active Triazoles - Mayo Clinic

    The purpose of this study is to describe representative real-world patterns of care for the management of invasive fungal infections (IFIs), including invasive ...

  9. In Clinical Trials - Mayo Clinic Research

    The purpose of this study is to assess the effectiveness and safety of Lubiprostone in pediatric patients, aged ≥ 6 years to < 18 years, diagnosed with ...

  10. Defibrotide for Patients with Hepatic Veno-occlusive Disease: A Treatment IND Study - Mayo Clinic

    Single arm, open-label study to provide Defibrotide to patients diagnosed with VOD. Defibrotide is no longer available though the Emergency Use IND mechanism ( ...